Valeo Pharma Inc.Valeo Pharma Inc.Valeo Pharma Inc.

Valeo Pharma Inc.

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
−0.04USD
Revenue estimate
‪11.29 M‬USD
Market capitalization
‪6.14 M‬USD
−0.2415USD
‪−20.04 M‬USD
‪38.84 M‬USD
‪32.21 M‬
Beta (1Y)
1.15

About VALEO PHARMA INC

CEO
Steven Saviuk
Headquarters
Kirkland
Employees (FY)
125
Founded
2003
FIGI
BBG00XD2Z731
Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. Its product portfolio includes respiratory/allergy, specialty products, ophthalmology, neurology, and oncology. The company was founded by Steven Saviuk on March 27, 2003 and is headquartered in Kirkland, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VPHIF is 0.1050 USD — it has decreased by 8.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Valeo Pharma Inc. stocks are traded under the ticker VPHIF.
Valeo Pharma Inc. is going to release the next earnings report on Jul 4, 2024. Keep track of upcoming events with our Earnings Calendar.
VPHIF stock is 9.05% volatile and has beta coefficient of 1.15. Check out the list of the most volatile stocks — is Valeo Pharma Inc. there?
VPHIF earnings for the last quarter are −0.07 USD per share, whereas the estimation was −0.04 USD resulting in a −87.50% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Valeo Pharma Inc. earnings.
Valeo Pharma Inc. revenue for the last quarter amounts to ‪9.44 M‬ USD despite the estimated figure of ‪12.07 M‬ USD. In the next quarter revenue is expected to reach ‪10.71 M‬ USD.
Yes, you can track Valeo Pharma Inc. financials in yearly and quarterly reports right on TradingView.
VPHIF stock has fallen by 6.25% compared to the previous week, the month change is a 16.20% fall, over the last year Valeo Pharma Inc. has showed a 79.99% decrease.
VPHIF net income for the last quarter is ‪−5.11 M‬ USD, while the quarter before that showed ‪−6.66 M‬ USD of net income which accounts for 23.26% change. Track more Valeo Pharma Inc. financial stats to get the full picture.
Today Valeo Pharma Inc. has the market capitalization of ‪6.86 M‬, it has increased by 0.06% over the last week.
No, VPHIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VPHIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Valeo Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
VPHIF reached its all-time high on Jan 25, 2021 with the price of 1.4000 USD, and its all-time low was 0.1000 USD and was reached on Oct 23, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 125.00 employees. See our rating of the largest employees — is Valeo Pharma Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Valeo Pharma Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Valeo Pharma Inc. stock shows the sell signal. See more of Valeo Pharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Valeo Pharma Inc. future price: according to them, VPHIF price has a max estimate of 0.44 USD and a min estimate of 0.29 USD. Read a more detailed Valeo Pharma Inc. forecast: see what analysts think of Valeo Pharma Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Valeo Pharma Inc. EBITDA is ‪−11.58 M‬ USD, and current EBITDA margin is −27.09%. See more stats in Valeo Pharma Inc. financial statements.